Helen Walsh
About Helen Walsh
Helen Walsh is a Senior Scientist at Supplant in Cambridge, England, where she has worked since 2020. She specializes in diagnostic techniques and has a strong background in plant genetics and molecular biology.
Work at The Supplant Company
Helen Walsh has been serving as a Senior Scientist at The Supplant Company since 2020, contributing her expertise in molecular biology and diagnostics. In this role, she has developed various diagnostic techniques, including LAMP, ELISA, and RT-qPCR. Prior to her current position, she worked as a Research Scientist at Supplant for eight months, focusing on molecular biology. Her work is based in Cambridge, England, where she has been instrumental in advancing the company's research initiatives.
Education and Expertise
Helen Walsh earned her Doctor of Philosophy (PhD) in Plant Genetics from the University of the Witwatersrand, where she studied from 2013 to 2019. She also holds an Honours Degree in Biology/Biological Sciences from the University of Pretoria, obtained in 2008, and a Master's degree in Virology from the same institution, completed in 2013. Her expertise includes plant tissue culture, specifically in the production and maintenance of friable embryonic callus, as well as the production of transgenic plant lines and micro- and macropropagation of plant lines.
Background
Before joining The Supplant Company, Helen Walsh worked as a Lab Manager at the University of the Witwatersrand from 2019 to 2020. In this role, she managed laboratory operations and supported research activities. Her academic journey began at the University of Pretoria, where she completed her Bachelor's degree in Microbiology from 2005 to 2007. This foundational education set the stage for her advanced studies and subsequent career in plant genetics and molecular biology.
Achievements
Helen Walsh has contributed significantly to the field of plant genetics through her research and development of diagnostic techniques. Her work on LAMP, ELISA, and RT-qPCR has enhanced the capabilities of The Supplant Company in molecular diagnostics. Additionally, her involvement in the production of transgenic plant lines showcases her commitment to advancing agricultural biotechnology.